Did you miss "Mad Money" on CNBC? If so, here are some of Jim Cramer's top takeaways.
In an "Executive Decision" segment, Cramer checked back in with Michael Neidorff, chairman and CEO of Centene Corp. (CNC) , the healthcare plan provider that has seen its shares fall from $98 to $89 a share as talks of another Obamacare repeal plan gain steam in Congress.
Neidorff said no matter what happens in Washington, Centene "will do OK." He said they're no stranger to block grants, which is something the latest Congressional plan favors.
As a matter of public policy, however, he said the plan shouldn't pass, as it will create different plans in every state and the states don't want that responsibility. Congress doesn't know what it wants to move toward, Neidorff said, only that it wants to change something.
As for the rest of his industry, Neidorff explained that most providers are very centralized and cannot handle state-level plans. Centene, by contrast, is very decentralized and operates at a local level.
Neidorff also commented on his company's merger with Fidelis, saying the deal will allow Centene to be the largest provider in the four largest states, something that will give them the scale they need for continued success.
Over on Real Money, Cramer looks at the newfound alliances with Amazon (AMZN) and the more aggressive style of those he thinks are being left behind. Get his insights with a free trial subscription to Real Money.
Cramer and the AAP team see a buying opportunity in Allergan (AGN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.